domingo, 12 de marzo de 2017

Few people actually benefit from 'breakthrough' cancer immunotherapy

Few people actually benefit from 'breakthrough' cancer immunotherapy





Few people actually benefit from ‘breakthrough’ cancer immunotherapy

By NATHAN GAY and VINAY PRASAD

No hay comentarios:

Publicar un comentario en la entrada